Atillasoy Ercem

CIK 00018188021 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001818802

Recent Transactions

19 trades

Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-21$8.48/sh−1,527→ 131,372 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-20$9.36/sh−568→ 132,899 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-20$8.48/sh−1,527→ 131,372 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-10-19$9.36/sh−568→ 132,899 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-21$5.38/sh−1,533→ 133,467 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-20$5.21/sh−563→ 135,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-07-01+14,000→ 135,563 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-07-01+26,000→ 26,000 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-04-21$5.86/sh−1,587→ 121,563 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-04-20$6.68/sh−453→ 123,150 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-25$8.24/sh−4,639→ 100,347 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2022-01-18+23,256→ 123,603 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2022-01-18+56,744→ 56,744 total
Sale
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-10-21$24.23/sh−1,514→ 104,986 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2021-01-19+28,000→ 106,500 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2021-01-19+52,000→ 52,000 total
Purchase
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-08-03$17.00/sh+3,500→ 78,500 total
Award
Kalaris Therapeutics, Inc.$KLRS
Common Stock
2020-07-29+75,000→ 75,000 total
Award
Kalaris Therapeutics, Inc.$KLRS
Stock Option (Right to Buy)
2020-07-29+407,400→ 407,400 total

Companies

Kalaris Therapeutics, Inc.
See Remarks
$KLRS

Recent Filings

Address

C/O ALLOVIR, INC. 139 MAIN STREET, SUITE 500

CAMBRIDGE, MA, 02142

View on SEC.gov